UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systemic therapy options in BRCA mutation-associated breast cancer

Breast cancer research and treatment, 2012-09, Vol.135 (2), p.355-366

2012

Volltextzugriff (PDF)

A Woman's Heart : The Impact of Adjuvant Endocrine Therapy on Cardiovascular Health

Cancer, 2009-05, Vol.115 (9), p.1813-1826

2009

Volltextzugriff (PDF)

A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up

Breast cancer research and treatment, 2015-11, Vol.154 (2), p.319-328

2015

Volltextzugriff (PDF)

Treating breast cancer in the 21st century: emerging biological therapies

Journal of Cancer, 2013-01, Vol.4 (2), p.117-132

2013

Volltextzugriff (PDF)

Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer

Breast cancer research and treatment, 2014-07, Vol.146 (2), p.321-328

2014

Volltextzugriff (PDF)

Adjuvant Chemotherapy for Early Breast Cancer: Optimal Use of Epirubicin

The oncologist (Dayton, Ohio), 2005-11, Vol.10 (10), p.780-791

Glück, Stefan

2005

Volltextzugriff (PDF)

Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe?

Current oncology reports, 2012-02, Vol.14 (1), p.1-11

2012

Volltextzugriff (PDF)

Molecularly targeted therapies for metastatic triple-negative breast cancer

Breast cancer research and treatment, 2013-02, Vol.138 (1), p.21-35

2013

Volltextzugriff (PDF)

Acceleration of Telomere Loss by Chemotherapy Is Greater in Older Patients with Locally Advanced Head and Neck Cancer

Clinical cancer research, 2006-11, Vol.12 (21), p.6345-6350

2006

Volltextzugriff (PDF)

Clinical and economic benefits of aromatase inhibitor therapy in early-stage breast cancer

American journal of health-system pharmacy, 2011-09, Vol.68 (18), p.1699-1706

2011

Volltextzugriff (PDF)

Frequency and Vehicle Capacity Determination using a Dynamic Transit Assignment Model

Transportation research record, 2019-03, Vol.2673 (3), p.574-585

2019

Volltextzugriff (PDF)

Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma

Journal of clinical oncology, 2008-05, Vol.26 (15), p.2489-2496

2008

Volltextzugriff (PDF)

Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal Women

Breast Cancer: Basic and Clinical Research, 2011-01, Vol.2011 (2011), p.209-226

2011

Volltextzugriff (PDF)

Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy

Breast cancer research and treatment, 2013-06, Vol.139 (3), p.759-767

2013

Volltextzugriff (PDF)

Consequences of the Convergence of Multiple Alternate Pathways on the Estrogen Receptor in the Treatment of Metastatic Breast Cancer

Clinical breast cancer, 2017-04, Vol.17 (2), p.79-90

Glück, Stefan, MD, PhD, FRCPC

2017

Volltextzugriff (PDF)

Erratum to: Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer

Breast cancer research and treatment, 2014-07, Vol.146 (2), p.329-329

2014

Volltextzugriff (PDF)

Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial

Journal of clinical oncology, 1999-03, Vol.17 (3), p.846-854

1999

Volltextzugriff (PDF)

Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer

Case reports in oncology, 2012-12, Vol.5 (3), p.687-692

2012

Volltextzugriff (PDF)

Participation in Cancer Clinical Trials: Why Are Patients Not Participating?

Medical decision making, 2014-01, Vol.34 (1), p.116-126

2014

Volltextzugriff (PDF)

nab -Paclitaxel for the Treatment of Aggressive Metastatic Breast Cancer

Clinical breast cancer, 2014-08, Vol.14 (4), p.221-227

Glück, Stefan

2014

Volltextzugriff (PDF)

Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast cancer: a case report and literature review

Journal of medical case reports, 2012-11, Vol.6 (1), p.413-413, Article 413

2012

Volltextzugriff (PDF)

Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians

Breast cancer research and treatment, 2016-07, Vol.158 (1), p.113-126

2016

Volltextzugriff (PDF)

Extending the Clinical Benefit of Endocrine Therapy for Women With Hormone Receptor–Positive Metastatic Breast Cancer: Differentiating Mechanisms of Action

Clinical breast cancer, 2014-04, Vol.14 (2), p.75-84

Glück, Stefan

2014

Volltextzugriff (PDF)

TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.781-791

2012

Volltextzugriff (PDF)

A woman's heart

Cancer, 2009-05, Vol.115 (9), p.1813-1826

2009

Volltextzugriff (PDF)

1 – 25 von 247

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(210)
Mit Volltextzugriff
(200)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(240)
Deutsch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(141)
Life Sciences & Biomedicine
(126)
Humans
(115)
Female
(96)
Oncology
(70)
Breast Cancer
(62)
Middle Aged
(57)
Adult
(47)
Aged
(44)
Breast Neoplasms - Drug Therapy
(44)
Breast Neoplasms - Pathology
(38)
Biological And Medical Sciences
(30)
Chemotherapy
(30)
Medical Sciences
(30)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(29)
Male
(26)
Medicine
(25)
Medicine & Public Health
(25)
Treatment Outcome
(22)
Cancer
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Systemic therapy options in BRCA mutation-associated breast cancer

A Woman's Heart : The Impact of Adjuvant Endocrine Therapy on Cardiovascular Health

A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up

Treating breast cancer in the 21st century: emerging biological therapies

Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer

Adjuvant Chemotherapy for Early Breast Cancer: Optimal Use of Epirubicin

Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe?

Molecularly targeted therapies for metastatic triple-negative breast cancer

Acceleration of Telomere Loss by Chemotherapy Is Greater in Older Patients with Locally Advanced Head and Neck Cancer

Clinical and economic benefits of aromatase inhibitor therapy in early-stage breast cancer

Frequency and Vehicle Capacity Determination using a Dynamic Transit Assignment Model

Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma

Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal Women

Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy

Consequences of the Convergence of Multiple Alternate Pathways on the Estrogen Receptor in the Treatment of Metastatic Breast Cancer

Erratum to: Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer

Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial

Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer

Participation in Cancer Clinical Trials: Why Are Patients Not Participating?

nab -Paclitaxel for the Treatment of Aggressive Metastatic Breast Cancer

Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast cancer: a case report and literature review

Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians

Extending the Clinical Benefit of Endocrine Therapy for Women With Hormone Receptor–Positive Metastatic Breast Cancer: Differentiating Mechanisms of Action

TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab

A woman's heart

Suchergebnisse filtern